IL92912A - Pararene derivatives with anti-stone activity, showing a typical signal in 3,101 parts per million in the spectrum of RMN-31C and a process for their preparation - Google Patents

Pararene derivatives with anti-stone activity, showing a typical signal in 3,101 parts per million in the spectrum of RMN-31C and a process for their preparation

Info

Publication number
IL92912A
IL92912A IL9291289A IL9291289A IL92912A IL 92912 A IL92912 A IL 92912A IL 9291289 A IL9291289 A IL 9291289A IL 9291289 A IL9291289 A IL 9291289A IL 92912 A IL92912 A IL 92912A
Authority
IL
Israel
Prior art keywords
reaction mixture
heparin
sodium
aqueous solution
sulfate
Prior art date
Application number
IL9291289A
Other languages
English (en)
Hebrew (he)
Other versions
IL92912A0 (en
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of IL92912A0 publication Critical patent/IL92912A0/xx
Publication of IL92912A publication Critical patent/IL92912A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Materials For Medical Uses (AREA)
  • Pyridine Compounds (AREA)
IL9291289A 1989-01-30 1989-12-28 Pararene derivatives with anti-stone activity, showing a typical signal in 3,101 parts per million in the spectrum of RMN-31C and a process for their preparation IL92912A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8903328A IT1234826B (it) 1989-01-30 1989-01-30 Derivati eparinici e procedimento per la loro preparazione

Publications (2)

Publication Number Publication Date
IL92912A0 IL92912A0 (en) 1990-09-17
IL92912A true IL92912A (en) 1994-06-24

Family

ID=11105069

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9291289A IL92912A (en) 1989-01-30 1989-12-28 Pararene derivatives with anti-stone activity, showing a typical signal in 3,101 parts per million in the spectrum of RMN-31C and a process for their preparation

Country Status (18)

Country Link
US (1) US5104860A (fr)
EP (1) EP0380943B1 (fr)
JP (1) JPH0678369B2 (fr)
KR (1) KR0161667B1 (fr)
AT (1) ATE111107T1 (fr)
AU (1) AU610034B2 (fr)
CA (1) CA2007616C (fr)
DE (1) DE69012154T2 (fr)
DK (1) DK0380943T3 (fr)
ES (1) ES2058609T3 (fr)
FI (1) FI96425C (fr)
IE (1) IE66563B1 (fr)
IL (1) IL92912A (fr)
IT (1) IT1234826B (fr)
NO (1) NO301719B1 (fr)
NZ (1) NZ232115A (fr)
PT (1) PT92991B (fr)
ZA (1) ZA90263B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US5250519A (en) * 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
IT1254216B (it) * 1992-02-25 1995-09-14 Opocrin Spa Derivati polisaccaridici di eparina, eparan solfato, loro frazioni e frammenti, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1260136B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
IT1260137B (it) * 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2 dell'acido alfa-l-iduronico-2-0-solfato
US5668118A (en) * 1992-07-24 1997-09-16 Cavalier Pharmaceuticals Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
US5296471A (en) * 1992-12-22 1994-03-22 Glycomed Incorporated Method for controlling o-desulfation of heparin and compositions produced thereby
US5336620A (en) * 1993-01-27 1994-08-09 American Home Products Corporation Process for the production of an anticoagulant composition
IT1264101B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici a struttura eparinica od eparanica modificati nella posizione 2
IT1264102B1 (it) * 1993-03-29 1996-09-10 Alfa Wassermann Spa Processo per la sintesi di glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonico sostituito con radicali
US20020055710A1 (en) 1998-04-30 2002-05-09 Ronald J. Tuch Medical device for delivering a therapeutic agent and method of preparation
AP1390A (en) * 1996-11-27 2005-04-15 Aventis Pharmaceuticals Products Inc Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound.
US6203536B1 (en) 1997-06-17 2001-03-20 Medtronic, Inc. Medical device for delivering a therapeutic substance and method therefor
US6106454A (en) * 1997-06-17 2000-08-22 Medtronic, Inc. Medical device for delivering localized radiation
US6013099A (en) 1998-04-29 2000-01-11 Medtronic, Inc. Medical device for delivering a water-insoluble therapeutic salt or substance
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
WO2002023190A2 (fr) * 2000-09-12 2002-03-21 Massachusetts Institute Of Technology Procedes et produits apparentes a l'heparine de faible poids moleculaire
AU2007200688B2 (en) * 2000-09-12 2010-02-04 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
EP2284535A1 (fr) * 2002-03-11 2011-02-16 Momenta Pharmaceuticals, Inc. Héparines de poids moléculaire faible
EP1582531A1 (fr) 2004-03-24 2005-10-05 Aventis Pharma S.A. Procédé d'oxydation d'héparines non-fractionnées et la détection de la présence ou de l'absence de glycosérine dans l'héparine et les produits dérivés de l'héparine.
EP1792621B1 (fr) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Dérivés de l'héparine administrables par voie orale
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
CN102791742B (zh) * 2010-01-19 2014-12-24 动量制药公司 评价肝素制剂
KR101794877B1 (ko) * 2010-09-14 2017-11-07 고쿠리츠 다이가쿠 호징 미야자키 다이가쿠 고순도 헤파린 및 그 제조방법
WO2012115952A1 (fr) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Évaluation de préparations d'héparine
EP3785720A1 (fr) 2012-05-09 2021-03-03 Cantex Pharmaceuticals, Inc. Traitement de la myélosuppression
EP3258941A4 (fr) 2015-02-17 2018-09-26 Cantex Pharmaceuticals, Inc. Traitement de cancers et de troubles de cellules souches hématopoïétiques privilégiés par interaction cxcl12-cxcr4
BR112022000255A8 (pt) 2019-07-09 2022-03-22 Optimvia Llc Métodos para sintetizar polissacarídeos anticoagulantes
EP4182452A4 (fr) 2020-07-14 2024-07-31 Optimvia Llc Procédés de synthèse de sulfate d'héparane non anticoagulant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5318520B2 (fr) * 1972-07-05 1978-06-15
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
DE3265781D1 (en) * 1981-05-21 1985-10-03 Akzo Nv New anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
IT1234826B (it) * 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione

Also Published As

Publication number Publication date
NO301719B1 (no) 1997-12-01
NO900392D0 (no) 1990-01-29
DE69012154T2 (de) 1995-02-23
IT1234826B (it) 1992-05-29
IT8903328A0 (it) 1989-01-30
JPH02240102A (ja) 1990-09-25
ATE111107T1 (de) 1994-09-15
FI900446A0 (fi) 1990-01-29
DE69012154D1 (de) 1994-10-13
NO900392L (no) 1990-07-31
CA2007616A1 (fr) 1990-07-30
ZA90263B (en) 1990-10-31
ES2058609T3 (es) 1994-11-01
DK0380943T3 (da) 1994-12-19
IE900316L (en) 1990-07-30
FI96425C (fi) 1996-06-25
KR900011789A (ko) 1990-08-02
KR0161667B1 (ko) 1998-11-16
FI96425B (fi) 1996-03-15
PT92991A (pt) 1990-07-31
EP0380943B1 (fr) 1994-09-07
IL92912A0 (en) 1990-09-17
IE66563B1 (en) 1996-01-24
AU610034B2 (en) 1991-05-09
AU4885890A (en) 1990-10-25
NZ232115A (en) 1991-05-28
PT92991B (pt) 1995-12-29
JPH0678369B2 (ja) 1994-10-05
CA2007616C (fr) 1996-05-14
EP0380943A1 (fr) 1990-08-08
US5104860A (en) 1992-04-14

Similar Documents

Publication Publication Date Title
EP0380943B1 (fr) Dérivés d'héparine et procédé pour leur préparation
US5010063A (en) Heparin derivatives and process for their preparation
US5013724A (en) Process for the sulfation of glycosaminoglycans, the sulfated glycosaminoglycans and their biological applications
US4981955A (en) Depolymerization method of heparin
US4933326A (en) Oligosaccharides obtained by heparin depolymerization having antiatherosclerotic activity
EP0014184B2 (fr) Fragments d'héparine ayant une activité anticoagulante sélective et procédé pour leur préparation
US4474770A (en) Oligosaccharides having anti-Xa activity, pharmaceutical compositions containing them and method of use
JPH0323528B2 (fr)
JPH03243601A (ja) 血液凝固の制御能をもつムコ多糖組成物およびその製造方法
WO1992002232A1 (fr) Fragments d'heparine presentant une activite d'inhibition de complement
JP2012526174A (ja) 新規なアシル化十糖類および抗血栓剤としてのこの使用
JP2012526172A (ja) 新規な硫酸化七糖類および抗血栓剤としてのこの使用
JP2714718B2 (ja) 新規硫酸化多糖及びその薬学的に許容される塩、その製造方法並びにそれを有効成分とする医薬
EP0600934A1 (fr) Oligosaccharides de sulfate de dermatan, procede de production, et compositions pharmaceutiques associees.
KR0184260B1 (ko) 항트롬보 활성을 지닌 황산화 글리코스아미노글리큐로난
JP2005533878A (ja) 非常に大きい硫酸化度を持つｋ５多糖体のエピマー化誘導体
US5470965A (en) Complexable heterogenous oligosaccharides and alpha-hydosanes having therapeutical activity, process for their preparation and related pharmaceutical compositions
WO1994029352A1 (fr) Polysaccharides a forte activite antithrombotique et aticoagulante
KR101104107B1 (ko) 헤파린으로부터 유도된 다당류의 혼합물, 이의 제조방법 및이를 함유하는 약제학적 조성물

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed